BRANNY, Marian, Pavel OSMANCIK, Petr KALA, Martin POLOCZEK, Dalibor HERMAN, Petr NEUZIL, Pavel HALA, Milos TABORSKY, Josef STASEK, Ludek HAMAN, Jan CHOVANCIK, Pavel CERVINKA, Jiri HOLY, Tomas KOVARNIK, David ZEMANEK, Stepan HAVRANEK, Vlastimil VANCURA, Petr PEICHL, Petr TOUSEK, Marek HOZMAN, Veronika LEKESOVA, Jiří JARKOVSKÝ, Martina NOVÁČKOVÁ, Klára BENEŠOVÁ, Petr Y WIDIMSKY a Vivek REDDY. Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trial. Journal of Cardiovascular Electrophysiology. HOBOKEN: Wiley-Blackwell, 2023, roč. 34, č. 9, s. 1885-1895. ISSN 1045-3873. Dostupné z: https://dx.doi.org/10.1111/jce.16029.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trial
Autoři BRANNY, Marian, Pavel OSMANCIK (garant), Petr KALA (203 Česká republika, domácí), Martin POLOCZEK (203 Česká republika, domácí), Dalibor HERMAN, Petr NEUZIL, Pavel HALA, Milos TABORSKY, Josef STASEK, Ludek HAMAN, Jan CHOVANCIK, Pavel CERVINKA, Jiri HOLY, Tomas KOVARNIK, David ZEMANEK, Stepan HAVRANEK, Vlastimil VANCURA, Petr PEICHL, Petr TOUSEK, Marek HOZMAN, Veronika LEKESOVA, Jiří JARKOVSKÝ (203 Česká republika, domácí), Martina NOVÁČKOVÁ (203 Česká republika, domácí), Klára BENEŠOVÁ (203 Česká republika, domácí), Petr Y WIDIMSKY a Vivek REDDY.
Vydání Journal of Cardiovascular Electrophysiology, HOBOKEN, Wiley-Blackwell, 2023, 1045-3873.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.700 v roce 2022
Kód RIV RIV/00216224:14110/23:00132260
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1111/jce.16029
UT WoS 001040991200001
Klíčová slova anglicky atrial fibrillation; bleeding; gastrointestinal bleeding; left atrial appendage closure; major bleeding; nonvitamin K anticoagulants
Štítky 14110211, 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 15. 11. 2023 09:04.
Anotace
IntroductionObservational studies have shown low bleeding rates in patients with atrial fibrillation (AF) treated by left atrial appendage closure (LAAC); however, data from randomized studies are lacking. This study compared bleeding events among patients with AF treated by LAAC and nonvitamin K anticoagulants (NOAC). MethodsThe Prague-17 trial was a prospective, multicenter, randomized trial that compared LAAC to NOAC in high-risk AF patients. The primary endpoint was a composite of a cardioembolic event, cardiovascular death, and major and clinically relevant nonmajor bleeding (CRNMB) defined according to the International Society on Thrombosis and Hemostasis (ISTH). ResultsThe trial enrolled 402 patients (201 per arm), and the median follow-up was 3.5 (IQR 2.6-4.2) years. Bleeding occurred in 24 patients (29 events) and 32 patients (40 events) in the LAAC and NOAC groups, respectively. Six of the LAAC bleeding events were procedure/device-related. In the primary intention-to-treat analysis, LAAC was associated with similar rates of ISTH major or CRNMB (sHR 0.75, 95% CI 0.44-1.27, p = 0.28), but with a reduction in nonprocedural major or CRNMB (sHR 0.55, 95% CI 0.31-0.97, p = 0.039). This reduction for nonprocedural bleeding with LAAC was mainly driven by a reduced rate of CRNMB (sHR for major bleeding 0.69, 95% CI 0.34-1.39, p = .30; sHR for CRNMB 0.43, 95% CI 0.18-1.03, p = 0.059). History of bleeding was a predictor of bleeding during follow-up. Gastrointestinal bleeding was the most common bleeding site in both groups. ConclusionDuring the 4-year follow-up, LAAC was associated with less nonprocedural bleeding. The reduction is mainly driven by a decrease in CRNMB.
VytisknoutZobrazeno: 17. 5. 2024 02:48